Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Broto

Showing results (491-500 of 555) with videos related to

Pageof 56
Sort By:
The Lancet. Oncology|February 19, 2020
Pazopanib for treatment of typical solitary fibrous tumours: a multicentre, single-arm, phase 2 trialJavier Martin-Broto, Josefina Cruz, Nicolas Penel, et al.
Breast Cancer Research and Treatment|February 12, 2022
Systemic treatment in advanced phyllodes tumor of the breast: a multi-institutional European retrospective case-series analysesE Palassini, O Mir, G Grignani, et al.
Cancers|March 6, 2021
A Growth Modulation Index-Based GEISTRA Score as a New Prognostic Tool for Trabectedin Efficacy in Patients with Advanced Soft Tissue Sarcomas: A Spanish Group for Sarcoma Research (GEIS) Retrospective StudyJavier Martínez-Trufero, Luis Miguel De Sande-González, Pablo Luna, et al.
Therapeutic Advances in Medical Oncology|November 6, 2024
Exploratory analysis of immunomodulatory factors identifies L1CAM as a prognostic marker in alveolar soft-part sarcomaJosé L Mondaza-Hernandez, Nadia Hindi, Antonio Fernandez-Serra, et al.
Ebiomedicine|July 17, 2024
Spatial distribution of tumour immune infiltrate predicts outcomes of patients with high-risk soft tissue sarcomas after neoadjuvant chemotherapySandro Pasquali, Viviana Vallacchi, Luca Lalli, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 12, 2024
CSF1R Inhibition in Patients with Advanced Solid Tumors or Tenosynovial Giant Cell Tumor: A Phase I Study of VimseltinibHans Gelderblom, Albiruni A Razak, Matthew H Taylor, et al.
Frontiers in Public Health|April 17, 2026
Tuberculosis outbreak in a pre-primary and primary school in Barcelona, SpainRaquel Prieto-García, Joan Pau Millet, Claudia Broto, et al.
ESMO Open|November 28, 2023
Efficacy of immune checkpoint inhibitors in alveolar soft-part sarcoma: results from a retrospective worldwide registryN Hindi, A Razak, E Rosenbaum, et al.
Annals of Surgical Oncology|April 15, 2026
ASO Visual Abstract: First-in-Human Study of CEB-01: Novel Loco-Regional SN-38-Releasing Membrane to Prevent Local Recurrence in Retroperitoneal SarcomasJosé Antonio Gonzalez, Ana Sebio, Javier Martin-Broto, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|June 2, 2021
The paediatric cancer clinical research landscape in Spain: a 13-year multicentre experience of the new agents group of the Spanish Society of Paediatric Haematology and Oncology (SEHOP)A Rubio-San-Simón, R Hladun Alvaro, A Juan Ribelles, et al.
Pageof 56

Showing results (491-500 of 555) with videos related to

Sort By:
Pageof 56
The Lancet. Oncology|February 19, 2020
Pazopanib for treatment of typical solitary fibrous tumours: a multicentre, single-arm, phase 2 trialJavier Martin-Broto, Josefina Cruz, Nicolas Penel, et al.
Breast Cancer Research and Treatment|February 12, 2022
Systemic treatment in advanced phyllodes tumor of the breast: a multi-institutional European retrospective case-series analysesE Palassini, O Mir, G Grignani, et al.
Cancers|March 6, 2021
A Growth Modulation Index-Based GEISTRA Score as a New Prognostic Tool for Trabectedin Efficacy in Patients with Advanced Soft Tissue Sarcomas: A Spanish Group for Sarcoma Research (GEIS) Retrospective StudyJavier Martínez-Trufero, Luis Miguel De Sande-González, Pablo Luna, et al.
Therapeutic Advances in Medical Oncology|November 6, 2024
Exploratory analysis of immunomodulatory factors identifies L1CAM as a prognostic marker in alveolar soft-part sarcomaJosé L Mondaza-Hernandez, Nadia Hindi, Antonio Fernandez-Serra, et al.
Ebiomedicine|July 17, 2024
Spatial distribution of tumour immune infiltrate predicts outcomes of patients with high-risk soft tissue sarcomas after neoadjuvant chemotherapySandro Pasquali, Viviana Vallacchi, Luca Lalli, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 12, 2024
CSF1R Inhibition in Patients with Advanced Solid Tumors or Tenosynovial Giant Cell Tumor: A Phase I Study of VimseltinibHans Gelderblom, Albiruni A Razak, Matthew H Taylor, et al.
Frontiers in Public Health|April 17, 2026
Tuberculosis outbreak in a pre-primary and primary school in Barcelona, SpainRaquel Prieto-García, Joan Pau Millet, Claudia Broto, et al.
ESMO Open|November 28, 2023
Efficacy of immune checkpoint inhibitors in alveolar soft-part sarcoma: results from a retrospective worldwide registryN Hindi, A Razak, E Rosenbaum, et al.
Annals of Surgical Oncology|April 15, 2026
ASO Visual Abstract: First-in-Human Study of CEB-01: Novel Loco-Regional SN-38-Releasing Membrane to Prevent Local Recurrence in Retroperitoneal SarcomasJosé Antonio Gonzalez, Ana Sebio, Javier Martin-Broto, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|June 2, 2021
The paediatric cancer clinical research landscape in Spain: a 13-year multicentre experience of the new agents group of the Spanish Society of Paediatric Haematology and Oncology (SEHOP)A Rubio-San-Simón, R Hladun Alvaro, A Juan Ribelles, et al.
Pageof 56